 HOUSTON, Texas and VANCOUVER, Canada, April 14, 2021 PRNewswire - ESSA Pharma Inc. ESSA or the Company Nasdaq: EPIX, a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that Dr. David R. Parkinson, Chief Executive Officer of ESSA Pharma, will be presenting at the upcoming Bloom Burton Co. Healthcare Investor Conference, taking place virtually April 20-21, 2021. 